Latest news
TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - StocktwitsStocktwits · Fri, 07 Aug 2026 09:03:29 GMTCorticosteroids, RAS Inhibitors, or Sparsentan First for FSGS? - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 06 Aug 2026 13:56:38 GMTInside the DUPLEX Trial: FSGS Design, Endpoints, and Exclusions - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 06 Aug 2026 12:14:52 GMT(FSGS) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.comnews.stocktradersdaily.com · Thu, 06 Aug 2026 09:14:02 GMTHong Kong Stock Market Movement | FSGS Sector Gains Momentum Again; LianBio (09637.HK) Surges Over 15%; Analysts Suggest Inclusion in Stock Connect Imminent - MoomooMoomoo · Wed, 05 Aug 2026 07:51:33 GMTTVTX: FILSPARI's record Q2 sales and rapid FSGS launch drive strong growth and future confidence - TradingViewTradingView · Tue, 04 Aug 2026 23:17:05 GMTFSGS Pathophysiology: Podocyte Injury Across the Lifespan - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 30 Jul 2026 12:12:31 GMTFSGS Subtypes and Genetics: Why Classification Still Falls Short - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 30 Jul 2026 12:12:31 GMT